A. Ernest Toth, Jr
2023
In 2023, A. Ernest Toth, Jr earned a total compensation of $1.1M as Chief Financial Officer at Aquestive Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $234,531 |
|---|---|
| Salary | $407,880 |
| Stock Awards | $448,700 |
| Other | $24,776 |
| Total | $1,115,887 |
Toth received $448.7K in stock awards, accounting for 40% of the total pay in 2023.
Toth also received $234.5K in non-equity incentive plan, $407.9K in salary and $24.8K in other compensation.
Rankings
In 2023, A. Ernest Toth, Jr's compensation ranked 1,090th out of 2,983 executives tracked by ExecPay. In other words, Toth earned more than 63.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,090 out of 2,983 | 64th |
Division Manufacturing | 646 out of 1,637 | 61st |
Major group Chemicals And Allied Products | 441 out of 906 | 51st |
Industry group Drugs | 430 out of 869 | 51st |
Industry Pharmaceutical Preparations | 294 out of 627 | 53rd |
Source: SEC filing on April 26, 2024.
Toth's colleagues
We found two more compensation records of executives who worked with A. Ernest Toth, Jr at Aquestive Therapeutics in 2023.